ArticleResearch square2026
Dimeric architecture and membrane thinning govern substrate recognition by human signal peptide peptidase.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Signal peptide peptidase (SPP) is an intramembrane aspartyl protease that cleaves transmembrane segments of diverse origin, such as remnant signal peptides of secretory proteins or transmembrane helices of tail-anchored proteins. Consistent with its ability to cleave multiple substrates, SPP is essential in mammals, and its activity is linked to a wide range of processes from immune regulation to protein quality control and cancer. Here we determine cryo-EM structures of human SPP in its apo form and bound to a signal peptide substrate. Together with molecular dynamics simulations and functional assays, our data show that SPP forms a constitutive homodimer that locally curves and thins the membrane, placing the conserved active site within the bilayer. Substrate engagement drives major conformational changes, including movement of a "latch" helix that positions the signal peptide for cleavage. The substrate adopts a tilted helix-unwound-β-strand architecture that defines the cleavage register independently of sequence. Steric exclusion by folded luminal domains or additional transmembrane helices explains selective processing of certain protein termini.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.